Avg closing price
Price range

11 Ken Griffin NeuBase Therapeutics Trades

The first NeuBase Therapeutics trade was made in Q4 2019. Since then Ken Griffin bought shares four more times and sold shares on six occasions. The investor sold all their shares in Q4 2022 and doesn't own any shares in NeuBase Therapeutics anymore.

Avg closing price
Price range
Sold -1.14 Thousand shares Q4 2022
Avg closing price $102.59
Price range $73.16 - $159.60
New holding (+1.14 Thousand shares) Q3 2022
Avg closing price $330.89
Price range $158.00 - $520.00
Sold -1.48 Thousand shares Q1 2022
Avg closing price $691.32
Price range $504.00 - $1,180.00
New holding (+1.48 Thousand shares) Q4 2021
Avg closing price $1,342.75
Price range $1,040.00 - $1,672.00
Sold -1.38 Thousand shares Q3 2021
Avg closing price $1,530.66
Price range $1,308.00 - $1,904.00
Increased shares by 101.9% (+698 shares) Q2 2021
Avg closing price $2,209.21
Price range $1,852.00 - $2,936.00
Sold 48.7% shares (-650 shares) Q1 2021
Avg closing price $3,624.52
Price range $2,768.00 - $4,944.00
Sold 9.7% shares (-143 shares) Q3 2020
Avg closing price $3,262.72
Price range $2,900.00 - $3,884.00
New holding (+1.48 Thousand shares) Q2 2020
Avg closing price $3,347.37
Price range $2,676.00 - $4,604.00
Sold -591 shares Q1 2020
Avg closing price $2,646.26
Price range $1,908.00 - $3,292.00
New holding (+591 shares) Q4 2019
Avg closing price $2,345.78
Price range $1,800.00 - $3,240.00

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!